[ORGANIZATION]
Veradermics
Featured in 4 tracked stories · first seen
Situations
GLP-1 weight-loss drug market trends
2 clusters · 5 sources · last updated
Latest: Pharmaceutical trends shift from weight loss to hair regrowth
The rise of GLP-1 weight-loss drugs, such as Ozempic, has created secondary market opportunities and medical concerns. In the cosmetics sector, the British chemical company Croda has seen a resurgence due to the demand f
Veradermics VDPHL01 clinical trial results
2 clusters · 4 sources · last updated
Latest: Veradermics experimental tablet shows promise in treating male hair loss
Veradermics, a Connecticut-based dermatological company, reported positive results from Phase III clinical trials for VDPHL01, an experimental oral pill designed to treat mild to moderate androgenetic alopecia in men. Th
Also covered in
-
Hair loss biotechs emerge as new Wall Street growth trade
[BUSINESS] · 3 sources ·